Clinical trial
Relative Bioavailability Study of Amlodipine Powder for Oral Solution, 5 mg (Base) Under Fasting and Fed Conditions
NCT05808725 is registered in ClinicalTrials.gov with Brillian Pharma Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relative Bioavailability Study of Amlodipine Powder for Oral Solution, 5 mg (Base) Under Fasting and Fed Conditions
- Lead sponsor
- Brillian Pharma Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 29, 2022
- Completion date
- April 17, 2023
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.